Mutual Fund Ownership
Ownership as on: Mon, 25 Nov, 2024

Nippon India Pharma Fund - Growth

NA
Equity
Amount Invested (Cr.)165.15
% of AUM1.90%

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth

NA
Equity
Amount Invested (Cr.)71.55
% of AUM1.42%

WhiteOak Capital Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)2.44
% of AUM1.05%

HDFC Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)12.54
% of AUM0.91%

Quant Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)3.82
% of AUM0.87%

FAQs about Thyrocare Technologies share price

Thyrocare Technologies is trading at 1001.85 as on Mon Nov 25 2024 09:59:53. This is 4.64% upper as compared to its previous closing price of 957.45.

The market capitalization of Thyrocare Technologies is 5064.96 Cr as on Mon Nov 25 2024 09:59:53.

The average broker rating on Thyrocare Technologies is Buy. The breakup of analyst rating is given below -

  • 0 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 0 analysts have given a hold rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a strong sell rating

The 52 wk high for Thyrocare Technologies is 1002.00 whereas the 52 wk low is 535.05

Thyrocare Technologies can be analyzed on the following key metrics -

  • TTM P/E: 51.45
  • Sector P/E: 29.91
  • Dividend Yield: 1.88%
  • D/E ratio: 0.04

Thyrocare Technologies reported a net profit of 70.76 Cr in 2024.

Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts